Anteotech Ltd · ASX:ADO
Anteotech — Anteo Diagnostics — Shareholder Meeting (November 2016)
24 slides from Anteotech's shareholder meeting presentation, Nov 14, 2016
Slide 1: Anteo Diagnostics Limited Annual General Meeting 2016
For personal use only Anteo Diagnostics Limited (ASX:ADO) Annual General Meeting 2016
Slide 2: Meeting Format
Meeting Format For personal use only 1. Chairman’s Welcome 2. Formal Resolutions 3. Group CEO Report 4. Other Business 5. Meeting Close. TEM image shows ~2 nm thick Mix&Go polymer films on 40 nm gold nanoparticles 2
Slide 3: Directors and Management in Attendance
Directors and Management in Attendance For personal use only Dr John Hurrell Dr Geoff Cumming Mr Rolf Sickman Mr Richard Martin Non-executive Non-executive Non-executive Non-executive Director Director Director Director Dr Jef Vangenechten Mr Peter Harding-Smith Ms Tamara Mills Group CEO Group CFO &
Slide 4: Formal Resolutions
Formal Resolutions For personal use only Resolution Description 1 Adoption of Directors’ Remuneration Report 2 Re-election of Director (Mr Rolf Sickman) 3 Re-election of Director (Dr Geoff Cumming) 4 Re-election of Director (Mr Mark Bouris) 5 Re-election of Director (Dr John Hurrell) 6 Approval of 1
Slide 5: Resolution Proxy Count
Resolution Proxy Count For personal use only Res Description For Against Open Excluded Abstain Totals 1 Adoption of Directors’ 248,024,387 79,096,799 15,395,282 45,802,884 11,388,480 399,707,832 Remuneration Report 2 Re-election of Director (Mr Rolf 344,465,570 31,824,002 13,447,837 4,664,800 5,305,
Slide 6: Group CEO Update
Group CEO Update For personal use only 1. New Executive team 2. Anteo: a true platform technology 3. Group vision 4. Diagnostics 5. Medical Devices 6. Energy 7. Conclusions 6
Slide 7: New Executive Team
New Executive Team For personal use only Dr Jef Vangenechten Ms Tamara Mills COO Mr Peter Harding-Smith Group CEO Australian Operations Group CFO Company Secretary - Appointed June 2016 - Appointed August ₋ Appointed October - Extensive business 2016 2016 experience - Extensive ₋ Chartered Accountan
Slide 8: A True Platform Technology
A True Platform Technology For personal use only Anteo Group Anteo Nano-chemistry technology has applications in a number of different industries 8
Slide 9: Current Focus
Current Focus For personal use only 1. Diagnostics and life sciences: effectively binding antibodies, antigens and other biological proteins to surfaces and beads (particles) 2. Medical Devices: to bond the nylon surface of sheaths and the lubricious hydrophilic coating. 3. Energy: Si anodes in Li-i
Slide 10: Group Vision
Group Vision For personal use only sales and operational cash flows operational maturity Assay Development DIAsource Platform ISO Manufacturing Commercialisation & BD 10
Slide 11: Group Vision
Group Vision For personal use only Diagnostic markets: • PoC Development • Products Anteo Technologies Medical Devices Energy 11
Slide 12: Group Vision
Group Vision For personal use only PoC Development DIAsource Anteo Platform Manufacturing Technologies Medical Devices Commercialisation Energy 12
Slide 13: Diagnostics and Life sciences
Diagnostics and Life sciences For personal use only o Core strengths Applying our technology at the smallest scale possible Point of Care space o Executing on multiple partnering opportunities: Commercial value beginning to follow through TEM images of Quantum Dots (10 nm) bound to Mix&Go o Ante
Slide 14: Diagnostic Revenue Sources
Diagnostic Revenue Sources For personal use only Professional Product Sales Services Direct R&D Distribution Custom Custom formulation Manufacturing Royalties Product Life Cycle 14
Slide 15: Financial strength DIAsource
Financial strength DIAsource For personal use only o From 2014 to 2016 the yearly revenue grew from 11.8m € to over 15m € o EBITDA increased from 10% to approaching 20% of revenue Sales by Quarter - Q1 2014 to Q3 2016 € 4,500,000 4,000,000 3,500,000 3,000,000 2,500,000 2,000,000 2014-Q1 2014-Q2 2014
Slide 16: Business Organization DIAsource
Business Organization DIAsource For personal use only ELISA Vitamin D RIA & Other Latin countries FraBeLux Product Specialists Marketing 16
Slide 17: Future Business Organization DIAsource
Future Business Organization DIAsource Synergy for commercialization and business development For personal use only Assay ELISA Components Vitamin D RIA & Other Anteo Products Direct Latin countries contacts FraBeLux Distributors Product Specialists Marketing 17
Slide 18: Group Vision
Group Vision For personal use only Business Development DIAsource Anteo Platform Technologies ISO Manufacturing Medical Devices Energy 18
Slide 19: Anteo – Medical Device
Anteo –– Medical Device Our goal: For personal use only To collaborate with Medical Device partners to achieve better and safer outcomes for patients through innovative surface modification. Multiple ongoing development collaborations with Cook Medical Actively strengthening Anteo’s IP position in t
Slide 20: Group Vision
Group Vision For personal use only DIAsource Anteo Platform Technologies Manufacturing Medical Devices Energy 20
Slide 21: Anteo Energy
Anteo Energy • Anteo coating provides strong bonds For personal use only between silicon and binder which enhances structural integrity. • Proof of principle data shows • Increased energy capacity Without Anteo technology • Increased battery life Example of SEM images of electrodes after >500 deep c
Slide 22: Anteo Energy
Anteo Energy For personal use only • Partner with expert Li-ion RnD partner to accelerate industry standard data package generation • Intention of entering commercial development arrangements with one or more of the following organizations. 22
Slide 23: Conclusion
Conclusion For personal use only • Current capabilities: • Greater acceptance of Anteo’s technology in the Diagnostic market • Increase financial strength with the acquisition of DIAsource • Deeper Commercial experience with the DIAsource and new Senior management team • This will lead to: • Greater
Slide 24: Thank you for your time, your interest and your continued support
For personal use only Thank you for your time, your interest and your continued support 24
Anteo Diagnostics — Shareholder Meeting (November 2016) on 6ix